Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by BaconIsBadon Apr 26, 2017 1:13pm
276 Views
Post# 26169279

RE:RE:RE:RE:RE:RE:RE:RE:RE:Low cost production is great however

RE:RE:RE:RE:RE:RE:RE:RE:RE:Low cost production is great howeverCongratulations on naming the two invesments that APH is in that is currently in the red. Your original comment was "all the bad invesments they have been making". I show you the other invesments that have been profitable and you ignore it. Man... I'd like to take a look at your investment history and pick out 2 stocks that have unrealized losses and call you a bad investor. I don't know if this is news to you, but sometimes investments take time to get a ROI, but you knew this already, right?

Ok. Here's some information from investor relations at WEED:

"Hi ×××××,
 
Thank you for your email. As we already have Health Canada authorization to produce the Leafs By Snoop line this will not affect the product line. Please let me know if you have any other questions.
 
Have a great day,
 
Meghan Customer Care Specialist"

That right there shows some carefully selected words to not cause panic. They have authorization to grow the line, but nowhere in there does it say that they will be able to advertise it as planned. Looks like their gamble to associate themselves with a 90's rapper might not pay off. Sorry for your loss.

alter000 wrote: How is CMM and KALY profitable TO Aphria? Not only they bought high, those company are not generating revenue for Aphria. CMM prodviding them data, KALY has nothing yet. 

I didn't 5 star my own post lol. I dont know who gave me 5 star, but I'm glad someone understand what i'm trying to say. Btw, Canopy bought Mettrum for roguhly 400 mil, and they had similar revenue as APH(Mettrum had 5 millions in Q3 with bare inventory). It is an amazing deal consider APH has market cap of lile 750 mil right now yet having the same revenue as Mettrum. Thats call a good investment. Even if Mettrum's brand is damaged, the licesed production space, clinic, and patients are worth it. What they can do is to remove Mettrum brand and use all the space for Tweed. And lastly, in store advertiment is allowed, and also medical program will stay the same. Snopp's name will be there just as it is in medical space. Dont believe me? Email the investor relation. 


Bullboard Posts